What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II...

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Myosin II and Rho-associated coiled-coil containing protein kinase (ROCK) are critical for cancer cell invasion and metastasis.
• Understanding the multifaceted roles of these proteins in melanoma progression is crucial.

Purpose of the Study:

• To investigate the dual role of Myosin II-ROCK pathway in melanoma drug resistance.
• To elucidate the involvement of this pathway in both intrinsic tumor cell protection and extrinsic immune suppression.

Main Methods:

• Analysis of Myosin II and ROCK signaling in melanoma cells.
• Assessment of tumor cell protection against reactive oxygen species (ROS) and DNA damage.
• Investigation of immune cell co-option by melanoma cells.

Main Results:

• Myosin II-ROCK pathway confers intrinsic resistance by protecting melanoma cells from ROS and DNA damage.
• This pathway extrinsically promotes immunosuppression through co-option of myeloid and lymphoid populations.
• The dual role highlights the pathway's significance in melanoma progression and therapeutic resistance.

Conclusions:

• The Myosin II-ROCK pathway is a key determinant of drug resistance in melanoma.
• Targeting this pathway could offer novel therapeutic strategies for melanoma treatment.
• Both intrinsic protective mechanisms and extrinsic immune modulation contribute to the pathway's oncogenic function.